Literature DB >> 1663528

Dissociated recovery of cortisol and dehydroepiandrosterone sulphate after treatment for Cushing's syndrome.

H Kleiber1, F Rey, E Temler, F Gomez.   

Abstract

We have studied the variation of ACTH, cortisol and DHEA-S plasma levels in 6 patients before and up to 15 months after surgical remission of Cushing's syndrome in order to compare the relative dependency of cortisol and adrenal androgens towards ACTH. Three patients with adrenal adenoma were treated by unilateral adrenalectomy. Three other patients with Cushing's disease underwent transsphenoidal pituitary tumorectomy. Preoperative ACTH was undetectable in patients with adrenal adenoma and high-normal or elevated in patients with Cushing's disease. All patients became rapidly hypocortisolemic after surgery and ACTH and cortisol levels eventually recovered at different intervals. Patients with adrenal adenoma had an initially low DHEA-S which failed to normalize for the entire follow-up period. Patients with Cushing's disease had normal or high-normal DHEA-S which became low immediately after surgery, following ACTH decrease, and it remained low during the entire follow-up period. In conclusion, after removal of corticotropic inhibition secondary to excess cortisol, DHEA-S remains suppressed for a longer period of time than cortisol. Moreover it only takes a short period of relatively low ACTH (after pituitary tumor excision) to induce a long lasting DHEA-S inhibition. Therefore the DHEA-S secreting adrenal cells seem to be more sensitive to the lack of corticotropic stimulation than cortisol secreting cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663528     DOI: 10.1007/BF03346848

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  5 in total

1.  The adrenal androgen-stimulating hormone does not exist.

Authors:  D C Anderson
Journal:  Lancet       Date:  1980-08-30       Impact factor: 79.321

2.  Dissociation between cortisol and adrenal androgen secretion in patients receiving alternate day prednisone therapy.

Authors:  P C Avgerinos; G B Cutler; G C Tsokos; P W Gold; P Feuillan; W T Gallucci; S R Pillemer; D L Loriaux; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1987-07       Impact factor: 5.958

3.  Evidence for existence of cortical androgen-stimulating hormone.

Authors:  L N Parker; W D Odell
Journal:  Am J Physiol       Date:  1979-06

4.  Dissociation of cortisol and adrenal androgen secretion in patients with secondary adrenal insufficiency.

Authors:  G B Cutler; S E Davis; R E Johnsonbaugh; D L Loriaux
Journal:  J Clin Endocrinol Metab       Date:  1979-10       Impact factor: 5.958

5.  Serum dehydroepiandrosterone sulfate in Cushing's syndrome.

Authors:  T Yamaji; M Ishibashi; H Sekihara; A Itabashi; T Yanaihara
Journal:  J Clin Endocrinol Metab       Date:  1984-12       Impact factor: 5.958

  5 in total
  2 in total

1.  Utility of plasma dehydroepiandrosterone sulphate determination in adrenal incidentalomas.

Authors:  G P Bernini; G F Argenio; M S Vivaldi; A Moretti; P Miccoli; P Iacconi; A Magagna; A Salvetti
Journal:  J Endocrinol Invest       Date:  1998-06       Impact factor: 4.256

2.  Limited Diagnostic Utility of Plasma Adrenocorticotropic Hormone for Differentiation between Adrenal Cushing Syndrome and Cushing Disease.

Authors:  A Ram Hong; Jung Hee Kim; Eun Shil Hong; I Kyeong Kim; Kyeong Seon Park; Chang Ho Ahn; Sang Wan Kim; Chan Soo Shin; Seong Yeon Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2015-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.